MEL-30152-74034
3 vaccinations
0 coded responses
21 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 229 / VA
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Pfizer-BioNTech
- 2021-01-14
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-15
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-17
- 2021-01-21
- 2021-01-28
-
2021-02-04
Dose 2 — Pfizer-BioNTech
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-05-06
- 2021-08-05
- 2022-02-04
-
2022-10-01
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-17
- 2022-10-22
- 2022-10-29
- 2022-11-05
- 2022-11-12
- 2023-01-02
- 2023-04-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-04 | Pfizer-BioNTech | |
| 3 | 2022-10-01 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.